Anti-Snoring Treatment Market Revenue Expected to Exceed $8.2 Billion

Selbyville, Delaware, April 22, 2021 (GLOBE NEWSWIRE) —

According to the latest report “Anti-Snoring Treatment Market by Devices (Mandible Advancement Devices, Tongue Stabilizer Devices, Nasal Devices, Continuous Positive Airway Pressure Devices, Chin Straps), Distribution Channel (Hospitals, Clinics, Pharmacies of retail, e-commerce), regional outlook, price trends, competitive market share and forecast 2027 »by Global Market Insights Inc., the market valuation of anti-snoring treatment will exceed USD 8.2 billion by 2027. Development of advanced anti-snoring devices to meet the increase in the population suffering from snoring will drive the growth of the market.

The expansion of the market is due to the growing prevalence of sleep disorders, including snoring. The adoption of an unhealthy and sedentary lifestyle leads to an increase in the number of obese individuals, which is considered to be one of the main causes responsible for the development of snoring. According to the American Sleep Association, approximately 50 to 70 million adults suffer from sleep disorders and approximately 48% of American adults report snoring. Thus, owing to the increase in the number of patients suffering from snoring, the market will continue to grow at a tremendous rate in the coming years.

Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/3998

The growing awareness of sleep disorders and their treatment has led to an increasing use of anti-snoring devices in the coming years. Companies operating in the industry are continually advancing processing solutions. For example, the US FDA recently approved eXciteOSA, the first daytime intraoral neuromuscular stimulation device used in the treatment of snoring. Some of the commonly used devices include mandible advancement devices, nasal devices, and continuous positive airway pressure devices. Additionally, anatomical abnormalities of the throat and nose, resulting in noisy breathing during sleep, will increase the demand for anti-snoring devices.

The nasal devices segment in the anti-snoring treatment market accounted for USD 665.8 million in 2020. Nasal anti-snoring devices are beneficial in relieving snoring. Nasal strips or dilators help keep the nostrils open during sleep. Developments of these devices lead to effective treatment of snoring and thus will drive the growth of the segment. Miniaturized, portable and flexible nasal devices meeting daily needs will further drive product demand.

The anti-snoring treatment market for hospitals exceeded USD 900 million in 2020. The increase in the number of patient visits to seek snoring treatment in hospitals will drive product sales through these establishments. Increasing awareness and promotion activities by industry players in hospitals and physicians with the availability of the products are expected to influence the value of the segment in the future. The required training and information regarding the use of the devices by doctors will further drive the preference of patients for hospitals and impact the segment revenue during the forecast period.

Anti-snoring treatment market in Asia-Pacific is expected to witness a growth rate of 9.2% through 2027, driven by the rising prevalence of obesity and acceptance of a sedentary lifestyle in the emerging economies. Additionally, the inclination towards advanced treatment therapies and treatment of sleep disorders will provide immense growth opportunities for the anti-snoring device market. Various established and start-up companies are coming in with new technologies for sleep monitoring and abnormality treatment. The growing accessibility of these technologies and increasing disposable income will fuel the growth of the APAC industry.

Request to customize this research report @

https://www.gminsights.com/roc/3998

Major companies operating in the anti-snoring treatment market include ResMed, Tomed Dr. Toussaint GmBH, Apnea Sciences Corporation, Pure Sleep Company, SomnoMed, Meditas, Philips Healthcare, and Fisher & Paykel Healthcare among others. Industry leaders implement various strategies such as product innovations, partnerships and collaborations to gain competitive advantage for business expansion.

Table of contents (ToC) of the report:

Chapter 3 Anti-Snoring Treatment Market Overview

3.1 Industry Segmentation

3.2 Industry Landscape, 2016-2027 (Million USD)

3.3 Industry impact forces

3.3.1 Drivers of growth

3.3.2 Industry Pitfalls and Challenges

3.4 Analysis of growth potential

3.4.1 By device

3.4.2 By distribution channel

3.5 COVID-19 Impact Analysis

3.6 Regulatory landscape

3.7 Porter’s analysis

3.8 Competitive Landscape, 2020

3.9 PESTEL analysis

Browse Full Table of Contents (ToC) @

https://www.gminsights.com/toc/detail/anti-snoring-treatment-market

About Global Market Insights Inc.

Global Market Insights Inc., headquartered in Delaware, USA, is a global provider of market research and advisory services, offering syndicated and custom research reports as well as consulting services. growth. Our business intelligence and industry research reports provide clients with in-depth insights and actionable market data specially designed and presented to aid in strategic decision-making. These comprehensive reports are designed through proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.